
Saniglor 90mg Tablet
Marketer
Syntonic Lifesciences
Salt Composition
Ticagrelor (90mg)
Overview Saniglor 90mg Tablet
Cardiogard 90mg tablets are antiplatelet agents, also known as blood thinners. They inhibit the formation of dangerous blood clots within blood vessels, thus lowering the risk of stroke or heart attack in individuals with cardiac conditions. Cardiogard 90mg tablets are also indicated for patients recovering from a myocardial infarction or experiencing unstable angina following coronary stenting. This medication helps prevent further cardiac events, including recurrent heart attacks, stroke, and clot formation within stents. Concomitant use with aspirin, another antiplatelet drug, is typically prescribed by your physician. Cardiogard 90mg tablets can be administered with or without food, consistently at the same time daily; uninterrupted use is crucial, even during periods of well-being. Cessation may significantly raise the risk of future cardiac events. The most prevalent adverse effect is increased bleeding tendency; injuries may bleed more profusely and for longer durations. While usually self-limiting and mild, prolonged or excessive bleeding should be reported. Some patients experience mild dyspnea, which typically subsides with ongoing treatment; however, worsening or persistent shortness of breath necessitates medical consultation. Cardiogard 90mg tablets are contraindicated in patients with active bleeding (e.g., ulcers, intracranial hemorrhage) or liver disease. Disclose any such conditions to your doctor before commencing treatment.
Uses of Saniglor 90mg Tablet
Averting cardiovascular events such as myocardial infarction and cerebrovascular accident
Major Benefits of Saniglor 90mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the 90mg Saniglor tablet whole; avoid crushing, chewing, or breaking it. Consumption with or without food is acceptable, though consistent timing is recommended.
Common Side effects of Saniglor 90mg Tablet:
- Bleeding
- Breathlessness
How to use Saniglor 90mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Saniglor 90mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Saniglor 90mg Tablet works:
CardioGuard 90mg tablets inhibit platelet aggregation, thus reducing the risk of dangerous thrombus formation and consequently minimizing the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while taking Saniglor 90mg tablets. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of Saniglor 90mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Saniglor 90mg Tablet usage while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Saniglor 90mg tablets.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Saniglor 90mg tablets without requiring a dosage change. However, data on Saniglor 90mg tablet use in individuals undergoing renal dialysis is scarce.
LiverCAUTION
Patients with liver impairment should use 90mg Saniglor tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Saniglor 90mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Saniglor 90mg Tablet :
Should you forget a Saniglor 90mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Saniglor 90mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Triazolopyrimidine compounds |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |
